MX2021010066A - Formulaciones agradables al paladar. - Google Patents

Formulaciones agradables al paladar.

Info

Publication number
MX2021010066A
MX2021010066A MX2021010066A MX2021010066A MX2021010066A MX 2021010066 A MX2021010066 A MX 2021010066A MX 2021010066 A MX2021010066 A MX 2021010066A MX 2021010066 A MX2021010066 A MX 2021010066A MX 2021010066 A MX2021010066 A MX 2021010066A
Authority
MX
Mexico
Prior art keywords
animal
soft chewable
animal based
veterinary
based palatant
Prior art date
Application number
MX2021010066A
Other languages
English (en)
Inventor
Paramjit Singh
Debendra Kumar Panda
Jeffrey Ellis Price
Atul Chhagan Badhan
Nicholas Finn Cunningham
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2021010066A publication Critical patent/MX2021010066A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

La presente invención está dirigida a una composición blanda y masticable que comprende o contiene una cantidad terapéuticamente efectiva de un agente activo veterinario, preferentemente un inhibidor de JAK; un mejorador del sabor con base animal, un mejorador del sabor con base no animal, un modificador del sabor, y al menos un excipiente aceptable en la veterinaria que se selecciona de un grupo que consiste en un desintegrador, aglutinante, lubricante, humectante, y deslizante; y en la que la tableta blanda y masticable se comprime con una compresora de tabletas giratoria; y métodos para tratar o prevenir el cáncer, asma, dermatitis atópica, enfermedades autoinmunes, prurito asociado con la dermatitis alérgica, alergias, y enfermedad respiratoria crónica en un animal.
MX2021010066A 2019-02-20 2020-02-19 Formulaciones agradables al paladar. MX2021010066A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962807871P 2019-02-20 2019-02-20
PCT/US2020/018762 WO2020172232A1 (en) 2019-02-20 2020-02-19 Palatable formulations

Publications (1)

Publication Number Publication Date
MX2021010066A true MX2021010066A (es) 2021-09-21

Family

ID=69960719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010066A MX2021010066A (es) 2019-02-20 2020-02-19 Formulaciones agradables al paladar.

Country Status (16)

Country Link
US (1) US20220062287A1 (es)
EP (1) EP3927315A1 (es)
JP (1) JP7442540B2 (es)
KR (1) KR20210114978A (es)
CN (1) CN113438941A (es)
AU (1) AU2020224102C1 (es)
BR (1) BR112021016480A2 (es)
CA (1) CA3127621A1 (es)
CL (1) CL2021002192A1 (es)
CO (1) CO2021010698A2 (es)
EC (1) ECSP21059181A (es)
IL (1) IL285078A (es)
MA (1) MA55027A (es)
MX (1) MX2021010066A (es)
UA (1) UA126843C2 (es)
WO (1) WO2020172232A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022004038A2 (pt) * 2019-09-06 2022-05-24 Elanco Us Inc Composições veterinárias granulares palatáveis
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
WO2023198476A1 (en) * 2022-04-15 2023-10-19 Krka, D.D., Novo Mesto Soft chewable veterinary dosage form
JP7355175B1 (ja) 2022-07-25 2023-10-03 フジテック株式会社 エレベータのブレーキ制動能力検査方法及びブレーキ制動能力検査装置
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique
EP1404303A4 (en) 2001-06-21 2006-03-15 Andrx Pharmaceuticals Inc STABLE PHARMACEUTICAL COMPOSITIONS BASED ON PRAVASTATIN
KR101030735B1 (ko) 2002-08-13 2011-04-26 인터벳 인터내셔널 비.브이. 첨가제를 전달하는 조성물 및 전달 방법
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
EP2063869B1 (en) 2006-09-07 2014-03-05 Merial Ltd. Soft chewable veterinary antibiotic formulations
DK2755498T3 (en) * 2011-09-15 2018-05-22 Friulchem Spa COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
CA2965524C (en) 2014-11-03 2020-04-14 Zoetis Services Llc Palatable chewable veterinary composition
CN108712900A (zh) 2015-12-19 2018-10-26 第时间美国泛型药物有限公司 软咀嚼片剂药物制剂

Also Published As

Publication number Publication date
EP3927315A1 (en) 2021-12-29
MA55027A (fr) 2021-12-29
JP2022521245A (ja) 2022-04-06
KR20210114978A (ko) 2021-09-24
NZ779157A (en) 2023-10-27
CN113438941A (zh) 2021-09-24
US20220062287A1 (en) 2022-03-03
AU2020224102A1 (en) 2021-08-19
JP7442540B2 (ja) 2024-03-04
ECSP21059181A (es) 2021-11-30
CO2021010698A2 (es) 2021-08-30
CL2021002192A1 (es) 2022-04-01
CA3127621A1 (en) 2020-08-27
BR112021016480A2 (pt) 2021-10-13
AU2020224102B2 (en) 2022-09-08
UA126843C2 (uk) 2023-02-08
IL285078A (en) 2021-09-30
AU2020224102C1 (en) 2023-03-16
WO2020172232A1 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
MX2021010066A (es) Formulaciones agradables al paladar.
MX2021009246A (es) Inmunomoduladores, composiciones y metodos de los mismos.
PH12017501421A1 (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n`-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
MY192084A (en) Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
PT2054405E (pt) Novos derivados de biaril benzoimidazol e composição farmacêutica que compreende os mesmos
MX2021001807A (es) Combinacion de un inhibidor de histona desacetilasa y un inhibidor de proteina cinasa y uso farmaceutico de la misma.
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
MX2020008086A (es) Metodos y composiciones para tratar la apnea del sue?o.
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
NZ737536A (en) Substituted benzamides and methods of use thereof
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2022000027A (es) Extracto de ca?amo para tratamiento del dolor, cancer y epilepsia en animales.
EA201891931A1 (ru) Новые ингибиторы фосфатидилинозитол-3-киназы гамма
PH12019501900A1 (en) Treatment of hidradenitis suppurativa
EP4121019A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF NON-MALIGNANT RESPIRATORY DISEASE
CR20210587A (es) Inhibidores de molécula pequeña de quinasa inductora de nf-kb
MY196979A (en) Method of treating disease by auricular anesthesia of cranial nerves
PH12020500096A1 (en) Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor
MX2023003675A (es) Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2020011826A (es) Composiciones de combinacion que comprenden compuestos de bisfluoroalquil-1,4-benzodiazepinona y metodos de uso de las mismas.
MX2022004382A (es) Metodos para promover la produccion de scfa por microbiota intestinal.
PH12019502580B1 (en) Synergistic compositions comprising (r)-dimiracetam (1) and (s)-dimiracetam (2) in a non-racemic ratio
AU2018276273A1 (en) Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer
CA3156118A1 (en) INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE